1 April 2022
Australian Securities Exchange 20 Bridge Street
Sydney NSW 2000
Dartford and Gravesham expand upon existing Miya Precision contract
Expanded agreement with Dartford and Gravesham NHS Trust to include a new module of Miya Precision, Miya Emergency, along with reselling new partner Provation’s anaesthetics module
Provation is highly complementary to Alcidion’s partner network, with their cloud-based solution Provation® iPro providing an anaesthesia information management system
Total Contract Value (TCV) of
Melbourne, Victoria – Alcidion Group Limited (ASX:ALC) today advises that it has signed a 5 year agreement with Dartford and Gravesham NHS Trust to implement Alcidion’s new Miya Emergency module alongside the Provation® iPro anaesthetics management solution. Collectively, both technologies will alleviate pressure while focusing priorities for emergency department staff, theatres and recovery.
Healthcare professionals working in the A&E department of the trust’s Darent Valley Hospital will become the first in the NHS to use Miya Emergency, a new module of Alcidion’s emerging open standards EPR platform, Miya Precision, which is already being deployed across the trust.
Miya Emergency functionality will support efficient patient registration and triage and will also integrate requests and results from diagnostics. It will contribute directly to streamlined patient flow through emergency and onto the next care destination, as appropriate. Staff will also use the system to address monitoring and reporting requirements, including providing data for the national Emergency Care Data Set.
As part of the expanded agreement, Alcidion is pleased to partner for the first time with Provation. Provation has a leading digital, cloud-based, anaesthesia information management system (AIMS) called Provation® iPro, which will integrate with the trust’s existing solutions helping the trust move away from paper-based anaesthesia records.
Provation® iPro, the world’s first mobile AIMS, will automate and simplify anaesthesia documentation, and help staff to efficiently capture and manage patient information as they create a complete anaesthesia record. The system is expected to help the trust manage compliance and improve patient safety.
Neil Perry, director of digital transformation at Dartford and Gravesham NHS Trust, said: “From day one, our digital transformation has been focussed on delivering what our clinicians need. Clinicians working in areas like our A&E and theatres are under continual pressure. Deploying technologies that can alleviate clinical burden and make data more useful, is an important step on our journey. I look forward to seeing Miya Emergency and Provation® iPro in action and our clinical teams respond to the demands they face.”
Lynette Ousby, UK managing director for Alcidion, said: “Dartford and Gravesham are proof that a modern, modular EPR strategy can provide the tools clinical teams need, when they need them. This is about deploying technology that helps to make the right thing to do, the easiest thing to do, and providing trusts
Alcidion Group Limited | Level 10 9 Yarra Street SOUTH YARRA VIC 3141 | ABN 77 143 142 410 T +61 3 8060 6177 | W www.alcidion.com | E info@alcidion.com
$3.0M over 5 years
Expands upon Alcidion’s relationship with Dartford and Gravesham who were the first to implement
Miya Precision in the UK in March 2019 and are now the first to implement Miya Emergency
Highlights the value of our modular strategy whereby Alcidion can progressively meet the needs of
customers to improve clinical outcomes
with the flexibility they need, so that digitisation addresses organisational priorities in the right order. We are proud to continue to work with the trust in its digital journey.”
Kate Quirke, CEO for Alcidion, said: “It is always rewarding to see our technology applied to helping the NHS, and in this case highly regarded technology of one our partners. NHS organisations continue to show a real appetite for genuinely helpful technology, none more so than Dartford and Gravesham NHS Trust. I look forward to seeing the benefits emerge for healthcare professionals from this latest development.”